Interferon alfa-2b (Qingfengyuan Bio)

干扰素α-2b（庆丰源）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alfa-2b (Qingfengyuan Bio)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsNeoplasms
Approved Indications in ChinaNeoplasms
Original Approved Country/TerritoryMainland China
Original Approved Date2005/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHeilongjiang Qingfengyuan Bio-Engineering Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHeilongjiang Qingfengyuan Bio-Engineering Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksWikipediaDrugBankKEGG